Investment Analysts’ Recent Ratings Changes for Intuitive Surgical (ISRG)

Several analysts have recently updated their ratings and price targets for Intuitive Surgical (NASDAQ: ISRG):

• 7/16/2026 – Intuitive Surgical had its price target lowered by Truist Financial Corporation from $580.00 to $510.00. They now have a “buy” rating on the stock.
• 7/15/2026 – Intuitive Surgical was given a new $500.00 price target by Mizuho. They now have a “neutral” rating on the stock.
• 7/14/2026 – Intuitive Surgical was given a new $670.00 price target by Stifel Nicolaus.
• 7/13/2026 – Intuitive Surgical was given a new $512.00 price target by BTIG Research.
• 7/13/2026 – Intuitive Surgical had its price target lowered by TD Cowen from $585.00 to $520.00. They now have a “buy” rating on the stock.
• 7/13/2026 – Intuitive Surgical had its price target lowered by Royal Bank Of Canada from $650.00 to $600.00. They now have an “outperform” rating on the stock.
• 7/8/2026 – Intuitive Surgical is now covered by BMO Capital Markets. They set an “outperform” rating and a $518.00 price target on the stock.
• 7/8/2026 – Intuitive Surgical had its “buy” rating reaffirmed by Citigroup Inc..
• 7/8/2026 – Intuitive Surgical was upgraded by BMO Capital Markets to “strong-buy”.
• 7/6/2026 – Intuitive Surgical was given a new $430.00 price target by Evercore Inc.
• 6/13/2026 – Intuitive Surgical was upgraded by Wall Street Zen from “hold” to “buy”.
• 6/12/2026 – Intuitive Surgical had its price target lowered by Bank of America Corporation from $520.00 to $515.00.
• 6/2/2026 – Intuitive Surgical had its “overweight” rating reaffirmed by Piper Sandler. They now have a $580.00 price target on the stock.
• 6/2/2026 – Intuitive Surgical had its price target lowered by Deutsche Bank Aktiengesellschaft from $440.00 to $366.00. They now have a “sell” rating on the stock.
• 5/27/2026 – Intuitive Surgical was given a new $558.00 price target by The Goldman Sachs Group, Inc..
• 5/24/2026 – Intuitive Surgical was downgraded by Wall Street Zen from “buy” to “hold”.
• 5/19/2026 – Intuitive Surgical had its “hold (c)” rating reaffirmed by Weiss Ratings.
• 5/18/2026 – Intuitive Surgical had its price target lowered by Bank of America Corporation from $650.00 to $520.00. They now have a “buy” rating on the stock.

Insiders Place Their Bets

In other news, Director Amy L. Ladd sold 119 shares of the company’s stock in a transaction that occurred on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total transaction of $55,156.50. Following the completion of the sale, the director owned 120 shares in the company, valued at $55,620. This represents a 49.79% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction on Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total value of $169,656.00. Following the sale, the executive vice president directly owned 5,720 shares of the company’s stock, valued at approximately $2,426,080.80. This represents a 6.54% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 7,169 shares of company stock valued at $3,059,135. 0.60% of the stock is owned by company insiders.

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.